Phenobarbital-induced expression of cytochrome P450 genes

Acta Biochimica Polonica

Volumn 47, Issue 4, 2000, Pages 1093-1105

  Czekaj, Piotr ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

CAR; CYP2B; CYP2H1; CYP3A; Cytochrome P450; Orphan receptors; Phenobarbital; Phenobarbital responsive enhancer unit; PXR

Indexed keywords

CYTOCHROME P450; PHENOBARBITAL;

ANIMAL; BACILLUS; BINDING SITE; BIOLOGICAL MODEL; BIOSYNTHESIS; ENZYMOLOGY; GENETIC TRANSCRIPTION; GENETICS; HUMAN; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEIN MOTIF; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

AMINO ACID MOTIFS; ANIMALS; BACILLUS; BASE SEQUENCE; BINDING SITES; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; PHENOBARBITAL; PROTEIN BINDING; SEQUENCE HOMOLOGY, NUCLEIC ACID; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 0034585128     PISSN: 0001527X     EISSN: None     Source Type: Journal    
DOI: 10.18388/abp.2000_3962     Document Type: Review

References (57)

1. Nelson, D., Koymans, L., Kamataki, T., Stegeman, J., Feyereisen, R., Waxman, D., Waterman, M., Gotoh, O., Coon, M., Estabrook, R., Gunsalus, I. & Nebert, D. (1996) P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6, 1-42.
2. Denison, M. & Whitlock, J. (1995) Xenobiotic-inducible transcription of cytochrome P450 genes. J. Biol. Chem. 270, 18175-18178.
3. Guengerich, F. (1995) Human cytochrome P450 enzymes; in Cytochrome P450: Structure, Mechanisms and Biochemistry (Ortiz de Montellano, P., ed.) pp. 473-575, Plenum Press, New York.
4. Bartsch, H., Castegnaro, M., Rojas, M., Camus, A.-M., Alexandrov, K. & Lang, M. (1992) Expression of pulmonary cytochrome P4501A1 and carcinogen DNA adduct formation in high risk subjects for tobacco-related lung cancer. Toxicol. Lett. 64/65, 477-483.
5. Kato, S., Bowman, E., Harrington, A., Blomeke, B. & Shields, P. (1995) Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo. J. Natl. Cancer Inst. 87, 902-907.
6. Aust, S., Chignell, C., Bray, T., Kalyanaraman, B. & Mason, R. (1993) Contemporary issues in toxicology. Free radicals in toxicology. Toxicol. Appl. Pharmacol. 120, 168-178.
7. Dizdaroglu, M. (1998) Mechanisms of free radical damage to DNA; in DNA and Free Radicals: Techniques, Mechanisms and Applications (Aruoma, O. & Halliwell, B., eds.) pp. 3-26, OICA Int. Saint Lucia, London.
8. Villard, P.-H., Seree, E., Re, J.-L., De Meo, M., Barra, Y., Attolini, L., Dumenil, G., Catalin, J., Durand, A. & Lacarelle, B. (1998) Effects of tobacco smoke on the gene expression of the Gyp1a, Cyp2b, Cyp2e, and Cyp3a subfamilies in mouse liver and lung: Relation to single strand breaks of DNA. Toxicol. Appl. Pharmacol. 148, 195-204.
9. Czekaj, P. & Nowaczyk-Dura, G. (1996) Effects of different synthetic steroid combinations on the activity of mixed function oxidase system and on the morphology of rat liver. Exp. Toxic. Pathol. 48 (Suppl. II) 82-87.
10. Czekaj, P. & Nowaczyk-Dura, G. (1999) Inhibiting effect of ethinylestradiol/levonorgestrel combination on microsomal enzymatic activities in rat liver and kidney. Eur. J. Drug Metab. Pharmacokinet. 24, 243-248.
11. Czekaj, P., Wiaderkiewicz, A. & Wiaderkiewicz, R. (2000) Immunodetection of cytochrome P450 isoforms in fetus and adult female Wistar rats. Acta Pol. Toxicol. 1, 17-31.
12. Chien, J., Thummel, K. & Slattery, J. (1997) Pharmacokinetic consequences of induction of CYP2E1 by ligand stabilization. Drug Metab. Dispos. 25, 1165-1175.
13. Whitlock, J. & Denison, M. (1995) Human cytochrome P450 enzymes; in Cytochrome P450: Structure, Mechanisms and Biochemistry (Ortiz de Montellano, P., ed.) pp. 367-390, Plenum Press, New York.
14. Brockmöller, J., Cascorbi, I., Kerb, R., Sachse, C. & Roots, I. (1998) Polymorphisms in xenobiotic conjugation and disease predisposition. Toxicol. Lett. 102-103, 173-183.
15. Waxman, D. & Azaroff, L. (1992) Phenobarbital induction of cytochrome P-450 gene expression. Biochem. J. 281, 577-592.
16. Frueh, F., Zanger, U. & Meyer, U. (1997) Extent and character of phenobarbital-mediated changes in gene expression in the liver. Mol. Pharmacol. 51, 363-369.
17. Smith, G., Henderson, C., Parker, M., White, R., Bars, R. & Wolf, R. (1993) 1,4-Bis[2-(3,5-dichloropyridyloxy)]benzene, an extremely potent modulator of mouse hepatic cytochrome P-450 gene expression. Biochem. J. 289, 807-813.
18. Honkakoski, P., Moore, R., Washburn, K. & Negishi, M. (1998) Activation by diverse xenochemicals of the 51-base pair phenobarbital-responsive enhancer module in the Cyp2b10 gene. Mol. Pharmacol. 53, 597-601.
19. Chang, T., Yu, L., Maurel, P. & Waxman, D. (1997) Enhanced cyclophosphamide and ifosfamide activation in primary human hepatocyte cultures: Response to cytochrome P-450 inducers and autoinduction by oxazaphosphorines. Cancer Res. 57, 1946-1954.
20. Anderson, G. (1998) A mechanistic approach to antiepileptic drug interactions. Ann. Pharmacother. 32, 554-563.
21. Dogra, S., Whitelaw, M. & May, B. (1997) Transcriptional activation of cytochrome P450 genes by different classes of chemical inducers. Clin. Exp. Pharmacol. Physiol. 25, 1-9.
22. Shaw, P., Adesnik, M., Weiss, M. & Corcos, L. (1993) The phenobarbital-induced transcriptional activation of cytochrome P-450 genes is blocked by the glucocorticoid-progesterone antagonist RU486. Mol. Pharmacol. 44, 775-783.
23. Pinkus, R., Bergelson, S. & Daniel, V. (1993) Phenobarbital induction of AP-1 binding activity mediates activation of glutathione S-transferase and quinone reductase gene expression. Biochem. J. 290, 637-640.
24. BM-3 and other inducible bacterial P450 cytochromes: Biochemistry and regulation. Annu. Rev. Pharmacol. Toxicol. 31, 177-203.
25. Shaw, G. & Fulco, A. (1992) Barbiturate-mediated regulation of expression of the cytochrome P-450BM-3 gene of Bacillus megaterium by Bm3R1 protein. J. Biol. Chem. 267, 5515-5526.
26. BM-3 gene of Bacillus megaterium. J. Biol. Chem. 268, 2997-3004.
27. Kemper, B. (1998) Regulation of cytochrome P450 gene transcription by phenobarbital. Prog. Nucleic Acid Res. 61, 25-64.
28. He, J. & Fulco, A. (1991) A barbiturate-regulated protein binding to a common sequence in the cytochrome P450 genes of rodents and bacteria. J. Biol. Chem. 226, 7864-7869.
29. Rangarajan, P. & Padmanaban, G. (1989) Regulation of cytochrome P-450b/e gene expression by a heme- and phenobarbitone-modulated transcription factor. Proc. Natl. Acad. Sci. U.S.A. 86, 3963-3967.
30. Ramsden, R., Sommer, K.M. & Omiecinski, C.J. (1993) Phenobarbital induction and tissue-specific expression of the rat CYP2B2 gene in transgenic mice. J. Biol. Chem. 268, 21722-21726.
31. Park, Y., Li, H. & Kemper, B. (1996) Phenobarbital induction mediated by a distal CYP2B2 sequence in rat liver transiently transfected in situ. J. Biol. Chem. 271, 23725-23728.
32. BM1 in Bacillus megaterium. J. Biol. Chem. 273, 7996-8002.
33. Dogra, S. & May, B. (1997) Liver enriched transcription factors, HNF-1, HNF-3 and C/EBP are major contributors to the strong activity of the chicken CYP2H1 promoter in chick embryo hepatocytes. DNA Cell Biol. 16, 1407-1418.
34. Prabhu, L., Upadhya, P., Ram, N., Nirodi, C., Sultana, S., Vatsala, P., Mani, S., Rangarajan, P., Surolia, A. & Padmanaban, G. (1995) A model for the transcriptional regulation of the CYP2B1/B2 gene in rat liver. Proc. Natl. Acad. Sci. U.S.A. 92, 9628-9632.
35. Meyer, U. & Hoffmann, K. (1999) Phenobarbital-mediated changes in gene expression in the liver. Drug Metab. Rev. 31, 365-373.
36. Park, Y. & Kemper, B. (1996) The CYP2B1 proximal promoter contains a functional C/EBP regulatory element. DNA Cell Biol. 15, 693-701.
37. Trottier, E., Belzil, A., Stoltz, C. & Anderson, A. (1995) Localization of a phenobarbital-responsive element (PBRE) in the 5′-flanking region of the rat CYP2B2 gene. Gene 158, 263-268.
38. Stoltz, C., Vachon, M.-H., Trottier, E., Dubois, S., Paquet, Y. & Anderson, A. (1998) The CYP2B2 phenobarbital response unit contains an accessory factor element and a putative glucocorticoid response element essential for conferring maximal phenobarbital responsiveness. J. Biol. Chem. 273, 8528-8536.
39. Honkakoski, P., Zelko, I., Sueyoshi, T. & Negishi, M. (1998) The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. Mol. Cell. Biol. 18, 5652-5658.
40. Sueyoshi, T., Kawamoto, T., Zelko, I., Honkakoski, P. & Negishi, M. (1999) The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene. J. Biol. Chem. 274, 6043-6046.
41. Stoltz, C. & Anderson, A. (1999) Positive regulation of the rat CYP2B2 phenobarbital response unit by the nuclear receptor hexamer half-site nuclear factor 1 complex. Biochem. Pharmacol. 57, 1073-1076.
42. Honkakoski, P. & Negishi, M. (1997) Characterization of a phenobarbital-responsive enhancer module in mouse P450 Cyp2b10 gene. J. Biol. Chem. 272, 14943-14949.
43. Czekaj, P. (1996) Interakcje receptorów hormonu tarczycy i pochodnych witamin AiDz DNA. Post. Biol. Kom. 23, 261-278 (in Polish).
44. Hahn, C., Hansen, A. & May, B. (1991) Transcriptional regulation of the chicken CYP2H1 gene. J. Biol. Chem. 266, 17031-17039.
45. Dogra, S., Davidson, B. & May, B. (1999) Analysis of a phenobarbital-responsive enhancer sequence located in the 5′ flanking region of the chicken CYP2H1 gene: Identification and characterization of functional protein-binding sites. Mol. Pharmacol. 55, 14-22.
46. Enmrak, E. & Gustafsson, J. (1996) Orphan nuclear receptors - the first eight years. Mol. Endocrinol. 10, 1293-1307.
47. Baes, M., Gulick, T., Choi, H., Martinoli, M., Simha, D. & Moore, D. (1994) A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Mol. Cell. Biol. 14, 1544-1552.
48. Forman, B., Tzameli, I., Choi, H.-S., Chen, J., Simha, D., Seol, W., Evans, R. & Moore, D. (1998) Androstane metabolites bind to and deactivate the nuclear receptor CAR-β. Nature 395, 612-615.
49. Zhou, Z., Wong, C., Sar, M. & Wilson, E. (1994) The androgen receptor: An overview. Rec. Prog. Horm. Res. 49, 249-274.
50. Kliewer, S., Lehmann, J. & Willson, T. (1999) Orphan nuclear receptors: Shifting endocrinology into reverse. Science 284, 757-760.
51. Lehmann, J., McKee, D., Watson, M., Willson, T., Moore, J. & Kliewer, S. (1998) The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J. Clin. Invest. 102, 1016-102.
52. Hashimoto, H., Toide, K., Kitamura, R., Fujita, M., Tagawa, S., Itoh, S. & Kamataki, T. (1993) Gene structure of CYP3A4, an adult-specific form of cytochrome P450 in human livers, and its transcriptional control. Eur. J. Biochem. 218, 585-595.
53. Kliewer, S., Moore, J., Wade, L., Staudinger, J., Watson, M., Jones, S., McKee, D., Oliver, B., Wilson, T., Zetterström, R., Perlmann, T. & Lehmann, J. (1998) An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 92, 73-82.
54. Beato, M. (1989) Gene regulation by steroid hormones. Cell 56, 335-344.
55. Nebert, D. (1994) Drug-metabolizing enzymes in ligand-modulated transcription. Biochem. Pharmacol. I 47, 25-27.
56. Kornberg, R. & Lorch, Y. (1992) Chromatin structure and transcription. Annu. Rev. Cell Biol. 8, 563-587.
57. Sidhu, J. & Omiecinski, C. (1995) cAMP-associated inhibition of phenobarbital-inducible cytochrome P450 gene expression in primary hepatocyte cultures. J. Biol. Chem. 270, 12762-12773.